SPY441.40-4.34 -0.97%
DIA345.64-1.80 -0.52%
IXIC15,043.97-137.96 -0.91%

BRIEF-Revance Publishes Results On Static Glabellar Lines Treatment

reuters.com · 09/01/2021 08:30
BRIEF-Revance Publishes Results On Static Glabellar Lines Treatment

- Revance Therapeutics Inc RVNC:

  • REVANCE ANNOUNCES PUBLICATION OF RESULTS ON STATIC GLABELLAR LINES WITH REPEATED TREATMENT OF DAXIBOTULINUMTOXINA FOR INJECTION

  • REVANCE THERAPEUTICS - RESULTS SUGGEST EXTENDED DURATION OF THERAPEUTIC BENEFIT WITH DAXIBOTULINUMTOXINA FOR INJECTION CAN PRODUCE DERMAL REMODELING

  • REVANCE THERAPEUTICS- POST-HOC ANALYSIS SHOWS SUSTAINED IMPROVEMENT OF STATIC GLABELLAR LINES

Source text for Eikon: ID:nBw5hQZTta

Further company coverage: RVNC


((Reuters.Briefs@thomsonreuters.com;))